Cyagen’s comprehensive services cover the entire process of custom-engineered mouse and rat model generation: from transgenic/gene targeting strategy design, through model development, breeding, cryopreservation, and phenotype analysis. We offer a robust selection of stem cell products for research use, including cell lines, media, and differentiation kits. Our CRO service platforms provide everything required for drug discovery and preclinical research, including specialty cell and gene therapy (CGT) therapeutic areas, such as ophthalmology, immuno-oncology, and neuroscience.
Cyagen has performed projects for scientists and institutions in more than 100 countries, leading to the publication of over 6,300 academic articles, many of which were in the three major journals of CNS (Cell, Nature, Science). From its robust foundation in animal model development, to implementation of artificial intelligence (AI)-powered tools for data analysis and therapeutic discoveries, Cyagen provides one-stop solutions for accelerating basic research and new drug R&D with our unique offering of models, data, algorithms, and services.

All our animal models are specific pathogen free (SPF) and are generated in AAALAC accredited, OLAW assured facilities. Visit our website to learn more about what we do: https://www.cyagen.com/us/en/about-us/the-company.html